Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Sleep Disturbances and Idiopathic Intracranial Hypertension in Men
Sleep
P1 - Poster Session 1 (12:00 PM-1:00 PM)
5-003
N/A

Idiopathic intracranial hypertension (IIH) is characterized by increased intracranial pressure of unknown etiology. The consensus is that IIH predominantly affects obese women of childbearing age, with the male to female ratio ranging from 1:4 to 1:8 of IIH patients in the 14 to 60 age group. Males with IIH are reported to be four times more likely to be at high risk for obstructive sleep apnea (OSA) compared to age and BMI matched controls.

Our research group investigated the relationship between sleep disturbances and the characteristics of IIH in males and females. We performed a review of 54 clinical charts and in-laboratory polysomnography test results; 27 of these were IIH patients (9 males and 18 females), and 27 were patients free of neurological disease who served as a control group matched for age, sex and BMI.

Our preliminary results did not reveal any significant differences between the male and female IIH patients in terms of age and BMI. However, there was a trend for male IIH patients to have significantly more severe OSA compared to female IIH patients (mean respiratory disturbance index (RDI) 31.7 vs. 9.0 events/hr, p=0.07; mean apnea length 19.1 vs. 12.6 seconds, p<0.05; mean minimum oxygen saturation 84.8% vs. 91.1%, p=0.14). We plan to report on a larger sample of male IIH patients at the time of the conference, as well as ascertain gender differences in terms of whether the burden of IIH symptoms correlates with OSA severity.

There appears to be a significant sex difference in terms of OSA severity among male and female IIH patients. Given the notable sex differences and the paucity of outcome data in males, it is unknown as to what extent, if any, management strategies for IIH may need to differ in males and females.

Authors/Disclosures
Arina Bingeliene, MD
PRESENTER
No disclosure on file
Trevor Jairam, MD (Azure Condominium) Trevor Jairam has nothing to disclose.
No disclosure on file
Mark I. Boulos, MD, FRCPC, CSCN(EEG), MSc (Sunnybrook Health Sciences Centre) Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision AQ. Dr. Boulos has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Techspert. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sleep Medicine (journal). The institution of Dr. Boulos has received research support from Canadian Institutes of Health Research. The institution of Dr. Boulos has received research support from RLS Foundation. The institution of Dr. Boulos has received research support from Temerty Centre for AI Research and Education in Medicine (T-CAIREM). The institution of Dr. Boulos has received research support from Heart & Stroke Foundation of Canada. The institution of Dr. Boulos has received research support from Alternative Funding Plan from the Academic Health Sciences Centres of Ontario. The institution of Dr. Boulos has received research support from StrokeCog. The institution of Dr. Boulos has received research support from McLaughlin Centre for Molecular Medicine . The institution of Dr. Boulos has received research support from Zoll Itamar. The institution of Dr. Boulos has received research support from Toronto Dementia Research Alliance. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Jazz Pharmaceuticals. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Lundbeck.